ESR1 and breast neoplasm: Although the magnitude of DNA methylation changes associated with these factors is generally smaller than the differences observed between breast tumor vs. normal tissues or estrogen receptor (ER) positive vs. negative breast tumors, such epigenetic changes may still confer biologically and clinically significant effects.